Ignite Creation Date:
2024-05-06 @ 4:26 PM
Last Modification Date:
2024-10-26 @ 2:10 PM
Study NCT ID:
NCT04985721
Status:
RECRUITING
Last Update Posted:
2023-03-15
First Post:
2021-06-28
Brief Title:
A Trial of Pamiparib With Tislelizumab in Patients With Advanced Tumours With Homologous Recombination Repair Defects
Sponsor:
Peter MacCallum Cancer Centre Australia
Organization:
Peter MacCallum Cancer Centre Australia
Organization Data
Organization:
Peter MacCallum Cancer Centre Australia
Class:
OTHER
Study ID:
20044
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Peter MacCallum Cancer Centre Australia
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None